Neurology

Patients can present with chief complaints and symptoms that differ from the eventual diagnoses. The differences between aetiologies versus complications must be appreciated through careful evaluation and use of clinical investigations, laboratory testing, trial of hypotheses, and clinical gestalt.

Diencephalic syndrome (DS), first described by Russell in 1951, is a rare cause of failure to thrive in infants and young children with preservation of linear growth.

The identification of pathological elements that drive disease progression, so-called regulators, is essential when studying progressive diseases.

THE CURTAIN OPENED on the 8th European Academy of Neurology (EAN) 2022 Congress on 25th June 2022 in Vienna, Austria, with EAN President Claudio Bassetti welcoming more than 8,000 neurologists from around the world.

MLD is caused by an accumulation of sulfatides in various organs and predominantly the central nervous system (CNS). Patients have an initial period of normal development, then experience developmental delay or stagnation (Figure 1).

In glioblastoma (GB), patients’ reliable response assessment criteria are crucial in order to accurately compare the responsiveness of different therapies in clinical trials, and to differentiate between therapy-induced changes and true tumour progression.

This year’s European Academy of Neurology (EAN) Congress offered a plethora of sessions in different areas of neurology.

Brain tumour-related epilepsy (BTRE) is associated with diffuse lower-grade gliomas (DLGG) in up to 70–90% of cases.